Grifols | GRFS - 流動負債





流動負債 変化する 日付
Alaunos Therapeutics USD 595K 218K 2026-03
Arca Biopharma USD 16.63M 1.26M 2026-03
aTyr Pharma USD 11.7M 101.49M 2026-03
Bio Path USD 9.15M 468K 2026-03
Brainstorm Cell Therapeutics USD 11.76M 757K 2026-03
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Cara Therapeutics USD 11.04M 2K 2025-12
Esperion Therapeutics USD 300.36M 451K 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Grifols EUR 2.37B 156.97M 2025-12
Immunic USD 38.36M 7.74M 2026-03
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
TherapeuticsMD USD 5.82M 655K 2024-06